Preclinical profiling demonstrates GPC2 and GD2 expression in retinoblastoma samples and cell lines, highlighting potential cell-surface targets for therapeutic development.
Supplementary Figure 1. Expression of GPC2 and GD2 in retinoblastoma patient samples and cell lines (see related main Fig. 1).
No takes yet. Share an insight, caveat, or question.
Pascual‐Pasto et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: